Developing and Promoting eHealth innovation
  twitter Linkdin Flickr rrss

This project has received funding from the European Union’s 7th Framework Programme for research, technological development and demonstration under grant agreement no 320021


READi for Health innovation hub supports big pharma in the development of mHealth applications

 The READi for Health partner in Skåne Clinical Studies Sweden – Forum South has provided support to AstraZeneca in the development of mHealth applications, using the healthcare-based health innovation hub concept developed by the project. The study, involving both healthcare professionals and patients, was performed in close collaboration between clinical trial - designers - and big pharma personnel.

  

“Development of innovative and effective mHealth solutions require a customer centric approach to be accepted by the end users and to realize the true value they can bring to patients, health care professionals and health care systems. A fundamental part of this is to have direct access to these groups in a way that is also compatible with sprint developments and design cycles typically used in the digital industry. At the same time especially patients interest and integrity must be protected at all time. Many companies within mHealth will struggle to find these contacts in a structured way and hence this is a clear barrier for the development and innovation of mHealth.

 

Establishing a service like testbeds within the Health Care system is a unique and very interesting approach that will overcome this barrier. High standards of integrity and security can be applied at the same time that a flexible and agile development approach can be supported. In addition to the use of recruitment via patient advocacy groups this also offers a way to avoid the other risk of involving only the very most engaged patients in a population to represent the needs of the patients, resulting in non-optimal solution and patient benefits”, says Magnus Jörntén-Karlsson, Project Director, Intelligent Pharmaceuticals, AstraZeneca Gothenburg.

© 2013 Readi for Health - Developing and Promoting eHealth innovation